Acute hypoxia decreases plasma VEGF concentration in healthy humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 3, 2006, Pages

  Oltmanns, Kerstin M ^a   Gehring, Hartmut ^a   Rudolf, Sebastian ^a   Schultes, Bernd ^a   Hackenberg, Claudia ^a   Schweiger, Ulrich ^a   Born, Jan ^a   Fehm, Horst L ^a   Peters, Achim ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Catecholamines; Clamp; Cortisol; In vivo; Soluble Flt 1 receptor; Vascular endothelial growth factor

Indexed keywords

ADRENALIN; CATECHOLAMINE; GLUCOSE; HYDROCORTISONE; INSULIN; NORADRENALIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; FLT1 PROTEIN, HUMAN; OXYGEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A, HUMAN; VASCULOTROPIN A;

ADULT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; HYPOXIA; IN VITRO STUDY; INSULIN BLOOD LEVEL; MALE; OXYGEN SATURATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STRESS; SYSTOLIC BLOOD PRESSURE; ANOXIA; BLOOD; BLOOD PRESSURE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANOXIA; BLOOD GLUCOSE; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EPINEPHRINE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYDROCORTISONE; INSULIN; MALE; NOREPINEPHRINE; OXYGEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 33645092171     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00508.2004     Document Type: Article

References (50)

1. Belgore FM, Blann AD, Li-Saw-Hee FL, Beevers DG, and Lip GY. Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension. Am J Cardiol 87: 805-807, 2001.
2. Chou E, Suzuma I, Way KJ, Opland D, Clermont AC, Naruse K, Suzuma K, Bowling NL, Vlahos CJ, Aiello LP, and King GL. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue. Circulation 105: 373-379, 2002.
3. Dantz D, Bewersdorf J, Fruehwald-Schultes B, Kern W, Jelkmann W, Born J, Fehm HL, and Peters A. Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab 87: 835-840, 2002.
4. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, and Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140: 947-959, 1998.
5. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25: 581-611, 2004.
6. Ferrara N, Houck K, Jakeman L, and Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13: 18-32, 1992.
7. Fredriksson JM, Lindquist JM, Bronnikov GE, and Nedergaard J. Norepinephrine induces vascular endothelial growth factor gene expression in brown adipocytes through a beta-adrenoreceptor/cAMP/protein kinase A pathway involving Src but independently of Erk1/2. J Biol Chem 275: 13802-13811, 2000.
8. Freedman SB and Isner JM. Therapeutic angiogenesis for coronary artery disease. Ann Intern Med 136: 54-71, 2002.
9. Gerber HP, Condorelli F, Park J, and Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 272: 23659-23667, 1997.
10. Gozal D, Lipton AJ, and Jones KL. Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 25: 59-65, 2002.
11. Gunga HC, Kirsch K, Rocker L, Behn C, Koralewski E, Davila EH, Estrada MI, Johannes B, Wittels P, and Jelkmann W. Vascular endothelial growth factor in exercising humans under different environmental conditions. Eur J Appl Physiol Occup Physiol 79: 484-490, 1999.
12. Gunsilius E, Petzer AL, and Gastl GA. Blood levels of vascular endothelial growth factor in obstructive sleep apnea-hypopnea syndrome. Blood 99: 393-394, 2002.
13. Harmey JH and Bouchier-Hayes D. Vascular endothelial growth factor (VEGF), a survival factor for tumour cells: implications for anti-angiogenic therapy. Bioessays 24: 280-283, 2002.
14. Hoshi S, Nomoto K, Kuromitsu J, Tomari S, and Nagata M. High glucose induced VEGF expression via PKC and ERK in glomerular podocytes. Biochem Biophys Res Commun 290: 177-184, 2002.
15. Imagawa S, Yamaguchi Y, Higuchi M, Neichi T, Hasegawa Y, Mukai HY, Suzuki N, Yamamoto M, and Nagasawa T. Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 98: 1255-1257, 2001.
16. Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 47: 617-623, 2001.
17. Kahler CM, Prior C, and Gunsilius E. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 163: 1030-1031, 2001.
18. Kahler CM, Wechselberger J, Molnar C, and Prior C. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe night time hypoxia. Am J Respir Crit Care Med 167: 92-93, 2003.
19. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, and Voelkel NF. Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. Am J Respir Crit Care Med 163: 737-744, 2001.
20. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, and Izumi T. Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis. Am J Respir Crit Care Med 166: 382-385, 2002.
21. Koyanagi S, Kuramoto Y, Nakagawa H, Aramaki H, Ohdo S, Soeda S, and Shimeno H. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 63: 7277-7283, 2003.
22. Lavie L, Kraiczi H, Hefetz A, Ghandour H, Perelman A, Hedner J, and Lavie P. Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165: 1624-1628, 2002.
23. Lerman OZ, Galiano RD, Armour M, Levine JP, and Gurtner GC. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol 162: 303-312, 2003.
24. Machein MR, Kullmer J, Ronicke V, Machein U, Krieg M, Damert A, Breier G, Risau W, and Plate KH. Differential downregulation of vascular endothelial growth factor by dexamethasone in normoxic and hypoxic rat glioma cells. Neuropathol Appl Neurobiol 25: 104-112, 1999.
25. Maeda T, Kawane T, and Horiuchi N. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Endocrinology 144: 681-692, 2003.
26. Malhotra A and White DP. Obstructive sleep apnoea. Lancet 360: 237-245, 2002.
27. Maloney J, Wang D, Duncan T, Voelkel N, and Ruoss S. Plasma vascular endothelial growth factor in acute mountain sickness. Chest 118: 47-52, 2000.
28. Mani N, Khaibullina A, Krum JM, and Rosenstein JM. Activation of receptor-mediated angiogenesis and signaling pathways after VEGF administration in fetal rat CNS explants. J Cereb Blood Flow Metab 23: 1420-1429, 2003.
29. McColley SA, Stellmach V, Boas SR, Jain M, and Crawford SE. Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation. Am J Respir Crit Care Med 161: 1877-1880, 2000.
30. Meier M, O'Callaghan CJ, Gallacher B, Standl E, and Williams B. Hypoxia-induced vascular endothelial growth factor expression is potentiated by elevated glucose levels. Diabet Med 17: 248-249, 2000.
31. Meyer KC, Cardoni A, and Xiang ZZ. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. J Lab Clin Med 135: 332-338, 2000.
32. Mick GJ, Wang X, and McCormick K. White adipocyte vascular endothelial growth factor: regulation by insulin. Endocrinology 143: 948-953, 2002.
33. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Varticovski L, and Isner JM. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270: 31189-31195, 1995.
34. Natarajan R, Bai W, Lanting L, Gonzales N, and Nadler J. Effects of high glucose on vascular endothelial growth factor expression in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 273: H2224-H2231, 1997.
35. Oltmanns KM, Gehring H, Rudolf S, Schultes B, Rook S, Schweiger U, Born J, Fehm HL, and Peters A. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 169: 1231-1237, 2004.
36. Pavlicek V, Marti HH, Grad S, Gibbs JS, Kol C, Wenger RH, Gassmann M, Kohl J, Maly FE, Oelz O, Koller EA, and Schirlo C. Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary oedema. Eur J Appl Physiol 81: 497-503, 2000.
37. Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J, Yancopoulos GD, and Adamis AP. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin Invest 109: 805-815, 2002.
38. Richardson RS, Wagner H, Mudaliar SR, Henry R, Noyszewski EA, and Wagner PD. Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am J Physiol Heart Circ Physiol 277: H2247-H2252, 1999.
39. Roeckl W, Hecht D, Sztajer H, Waltenberger J, Yayon A, and Weich HA. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res 241: 161-170, 1998.
40. Santos S, Peinado VI, Ramirez J, Morales-Blanhir J, Bastos R, Roca J, Rodriguez-Roisin R, and Barbera JA. Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 1250-1256, 2003.
41. Satake S, Kuzuya M, Miura H, Asai T, Ramos MA, Muraguchi M, Ohmoto Y, and Iguchi A. Up-regulation of vascular endothelial growth factor in response to glucose deprivation. Biol Cell 90: 161-168, 1998.
42. Schobersberger W, Hobisch-Hagen P, Fries D, Wiedermann F, Rieder-Scharinger J, Villiger B, Frey W, Herold M, Fuchs D, and Jelkmann W. Increase in immune activation, vascular endothelial growth factor and erythropoietin after an ultramarathon run at moderate altitude. Immunobiology 201: 611-620, 2000.
43. Schulz R, Hummel C, Heinemann S, Seeger W, and Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 165: 67-70, 2002.
44. Shweiki D, Itin A, Soffer D, and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
45. Sone H, Deo BK, and Kumagai AK. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest Ophthalmol Vis Sci 41: 1876-1884, 2000.
46. Teramoto S, Kume H, Yamamoto H, Ishii T, Miyashita A, Matsuse T, Akishita M, Toba K, and Ouchi Y. Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome. Intern Med 42: 681-685, 2003.
47. Walter R, Maggiorini M, Scherrer U, Contesse J, and Reinhart WH. Effects of high-altitude exposure on vascular endothelial growth factor levels in man. Eur J Appl Physiol 85: 113-117, 2001.
48. Wang W, Merrill MJ, and Borchardt RT. Vascular endothelial growth factor affects permeability of brain microvessel endothelial cells in vitro. Am J Physiol Cell Physiol 271: C1973-C1980, 1996.
49. Wulff C, Wilson H, Rudge JS, Wiegand SJ, Lunn SF, and Fraser HM. Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap(A40). J Clin Endocrinol Metab 86: 3377-3386, 2001.
50. Zhao L, Zhang MM, and Ng KY. Effects of vascular permeability factor on the permeability of cultured endothelial cells from brain capillaries. J Cardiovasc Pharmacol 32: 1-4, 1998.